Patents by Inventor Nancy Pryer

Nancy Pryer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR TARGETED PROTEIN DEGRADATION
    Publication number: 20240174708
    Abstract: Provided are compounds, including compositions comprising the same, which function to recruit various target proteins (e.g., client proteins of 14-3-3 proteins) to an E3 ubiquitin ligase enzyme for ubiquitination and subsequent degradation, and methods of using the same.
    Type: Application
    Filed: October 3, 2023
    Publication date: May 30, 2024
    Inventors: Nancy PRYER, Christian OTTMANN, Steven RICHARDS
  • TREATMENT OF MELANOMA
    Publication number: 20100086518
    Abstract: Methods of treating melanoma include administering a compound of Structure I, a tautomer of the compound, a pharmaceutically acceptable salt of the compound, a pharmaceutically acceptable salt or the tautomer, or a mixture thereof to a subject. The compound, tautomer, salt of the compound, salt of the tautomer, or mixture thereof may be used to prepare medicaments for treating metastatic cancer. The variable A has the values defined herein.
    Type: Application
    Filed: March 7, 2008
    Publication date: April 8, 2010
    Applicant: NOVARTIS AG
    Inventors: Carla C. Heise, Paul Hollenbach, Daniel Menezes, Nancy Pryer, Katherine Rendahl, Marion Wiesmann
  • Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders
    Publication number: 20040152759
    Abstract: The invention relates to a method of treating cancer by administering a combination of an indolinone compound with another chemotherapeutic agent.
    Type: Application
    Filed: November 14, 2003
    Publication date: August 5, 2004
    Applicant: SUGEN, Inc.
    Inventors: Tinya Abrams, Lesley Murray, Nancy Pryer, Julie Cherrington